See Phan
Vice President, Clinical Research Oncology Gilead Sciences
See Phan, Vice President of Clinical Research in Oncology at Gilead Sciences, is a physician–scientist with more than two decades of experience in cancer research and drug development. He leads global clinical research efforts across Gilead’s oncology portfolio, overseeing the design and execution of trials aimed at advancing innovative therapies, including antibody-drug conjugates, for patients with high unmet need.
Prior to joining Gilead in 2020, Phan held senior leadership roles at Genentech and Pharmacyclics, contributing to late-stage oncology development and medical strategy. He earned his M.D. from Columbia University and completed his clinical training at Stanford, bringing deep expertise in hematology-oncology to his work.
Seminars
- Contextualizing ADC combinations as the future of effective clinical approaches as more ADCs advance to standard of care oncology settings
- Exploring ongoing work into Trodelvy-immunotherapy clinical combinations, focused on urothelial bladder cancer
- Highlighting rationale and vision for novel combinations to unlock the prospect of to deliver new heights of ADC powered patient impact
